The mpox virus spread globally earlier this year, bringing fears of another pandemic. Many western countries fought off the outbreak with treatments and vaccines. But in the Democratic Republic of the Congo, the virus remains endemic, as it has for decades. Special correspondent Benedict Moran and video journalist Jorgen Samso report.
Download logoNathalie looked upon her convalescent baby, hope slowly wiping away distress. Her 12-month-old boy had been admitted to St Luc Hospital in
At a village clinic in central Congo, separated from the world by a tangle of waterways and forests, six-year-old Angelika Lifafu grips her dress and screams while nurses in protective suits pick at one of hundreds of boils that trouble her delicate skin.
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).